Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 274 papers

Prioritization of therapeutic targets and trial design in cirrhotic portal hypertension

Abraldes JG, Trebicka J, Chalasani N, D'Amico G, Rockey DC, Shah VH, Bosch J, Garcia-Tsao G.

Hepatology 2019, 69(3): 1287–1299

DOI: 10.1002/hep.30314

Acute-on-chronic liver failure in patients with alcohol-related liver disease

Gustot T, Jalan R.

J Hepatol 2019, 70(2): 319–327

DOI: 10.1016/j.jhep.2018.12.008

Agreement of surgical blood loss estimation methods

Jaramillo S, Montane-Muntane M, Capitan D, Aguilar F, Vilaseca A, Blasi A, Navarro-Ripoll R.

Transfusion 2019, 59(2): 508–515

DOI: 10.1111/trf.15052

Left ventricular longitudinal contractility predicts acute-on-chronic liver failure development and mortality after transjugular intrahepatic portosystemic shunt

Jansen C, Schröder A, Schueler R, Lehmann J, Praktiknjo M, Uschner FE, Schierwagen R, Thomas D, Monteiro S, Nickenig G, Strassburg CP, Meyer C, Arroyo V, Hammerstingl C, Trebicka J.

Hepatol Commun 2019, 3(3): 340–347

DOI: 10.1002/hep4.1308

Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome

Lopategi A, Flores-Costa R, Rius B, López-Vicario C, Alcaraz-Quiles J, Titos E, Clària J.

J Leukoc Biol 2019, 105(1): 25–36

DOI: 10.1002/JLB.3HI0517-206RR

Management of acute liver failure – Clinical guideline from the Catalan Society of Digestology

Escorsell À, Castellote J, Sánchez-Delgado J, Charco R, Crespo G, Fernández J.

Gastroenterol Hepatol 2019, 42(1): 51–64

DOI: 10.1016/j.gastrohep.2018.07.013

Preemptive-TIPS improves outcome in high-risk variceal bleeding: An observational study

Hernández-Gea V, Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Ibañez-Samaniego L, Silva-Junior G, Martinez J, Genescà J, Bureau C, Trebicka J, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Noronha Ferreira C, Barcelo R, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernández-Guerra M, Sassatelli R, Dell'Era A, Senzolo M, Abraldes JG, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Primignani M, Krag A, Nevens F, Calleja JL, Jansen C, Robic MA, Conejo I, Catalina MV, Albillos A, Rudler M, Alvarado E, Guardascione MA, Tantau M, Bosch J, Torres F, Garcia-Pagán JC; International Variceal Bleeding Observational Study Group and Baveno Cooperation

Hepatology 2019, 69(1): 282–293

DOI: 10.1002/hep.30182

Statins: Old drugs as new therapy for liver diseases?

Pose E, Trebicka J, Mookerjee RP, Angeli P, Ginès P.

J Hepatol 2019, 70(1): 194–202

DOI: 10.1016/j.jhep.2018.07.019

Acute-on-chronic liver failure vs. traditional acute decompensation of cirrhosis

Gustot T, Moreau R.

J Hepatol 2018, 69(6): 1384–1393

DOI: 10.1016/j.jhep.2018.08.024

Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: Study protocol for a randomized controlled trial

Madsen BS, Trebicka J, Thiele M, Israelsen M, Arumugan M, Havelund T, Krag A.

Trials 2018, 19(1): 143

DOI: 10.1186/s13063-018-2523-9